Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Endothelin Receptor Antagonist Market Report 2016

  • QYR679024
  • 124 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Endothelin Receptor Antagonist

Revenue, means the sales value of Endothelin Receptor Antagonist

This report studies sales (consumption) of Endothelin Receptor Antagonist in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Actelion Pharmaceuticals Ltd.

United Therapeutics Corporation

Gilead sciences

Bayer AG

SteadyMed Ltd.

GlaxoSmithKline plc

Pfizer Inc.

Reata Pharmaceuticals Inc.

Arena Pharmaceuticals Inc.

Merck & Co. Inc

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Endothelin Receptor Antagonist in each application, can be divided into

Health care

Clinic

Hospital

Table of Contents

United States Endothelin Receptor Antagonist Market Report 2016

1 Endothelin Receptor Antagonist Overview

1.1 Product Overview and Scope of Endothelin Receptor Antagonist

1.2 Classification of Endothelin Receptor Antagonist

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Endothelin Receptor Antagonist

1.3.1 Health care

1.3.2 Clinic

1.3.3 Hospital

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Endothelin Receptor Antagonist (2011-2021)

1.4.1 USA Endothelin Receptor Antagonist Sales and Growth Rate (2011-2021)

1.4.2 USA Endothelin Receptor Antagonist Revenue and Growth Rate (2011-2021)

2 USA Endothelin Receptor Antagonist Competition by Manufacturers

2.1 USA Endothelin Receptor Antagonist Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Endothelin Receptor Antagonist Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Endothelin Receptor Antagonist Average Price by Manufactures (2015 and 2016)

2.4 Endothelin Receptor Antagonist Market Competitive Situation and Trends

2.4.1 Endothelin Receptor Antagonist Market Concentration Rate

2.4.2 Endothelin Receptor Antagonist Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Endothelin Receptor Antagonist Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Endothelin Receptor Antagonist Sales and Market Share by Type (2011-2016)

3.2 USA Endothelin Receptor Antagonist Revenue and Market Share by Type (2011-2016)

3.3 USA Endothelin Receptor Antagonist Price by Type (2011-2016)

3.4 USA Endothelin Receptor Antagonist Sales Growth Rate by Type (2011-2016)

4 USA Endothelin Receptor Antagonist Sales (Volume) by Application (2011-2016)

4.1 USA Endothelin Receptor Antagonist Sales and Market Share by Application (2011-2016)

4.2 USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Endothelin Receptor Antagonist Manufacturers Profiles/Analysis

5.1 Actelion Pharmaceuticals Ltd.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 United Therapeutics Corporation

5.2.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Gilead sciences

5.3.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Bayer AG

5.4.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 SteadyMed Ltd.

5.5.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 GlaxoSmithKline plc

5.6.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Pfizer Inc.

5.7.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Reata Pharmaceuticals Inc.

5.8.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Arena Pharmaceuticals Inc.

5.9.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Merck & Co. Inc

5.10.2 Endothelin Receptor Antagonist Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Merck & Co. Inc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Endothelin Receptor Antagonist Manufacturing Cost Analysis

6.1 Endothelin Receptor Antagonist Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Endothelin Receptor Antagonist

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Endothelin Receptor Antagonist Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Endothelin Receptor Antagonist Market Forecast (2016-2021)

10.1 USA Endothelin Receptor Antagonist Sales, Revenue Forecast (2016-2021)

10.2 USA Endothelin Receptor Antagonist Sales Forecast by Type (2016-2021)

10.3 USA Endothelin Receptor Antagonist Sales Forecast by Application (2016-2021)

10.4 Endothelin Receptor Antagonist Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Endothelin Receptor Antagonist

Table Classification of Endothelin Receptor Antagonist

Figure USA Sales Market Share of Endothelin Receptor Antagonist by Type in 2015

Table Application of Endothelin Receptor Antagonist

Figure USA Sales Market Share of Endothelin Receptor Antagonist by Application in 2015

Figure Health care Examples

Figure Clinic Examples

Figure Hospital Examples

Figure USA Endothelin Receptor Antagonist Sales and Growth Rate (2011-2021)

Figure USA Endothelin Receptor Antagonist Revenue and Growth Rate (2011-2021)

Table USA Endothelin Receptor Antagonist Sales of Key Manufacturers (2015 and 2016)

Table USA Endothelin Receptor Antagonist Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Endothelin Receptor Antagonist Sales Share by Manufacturers

Figure 2016 Endothelin Receptor Antagonist Sales Share by Manufacturers

Table USA Endothelin Receptor Antagonist Revenue by Manufacturers (2015 and 2016)

Table USA Endothelin Receptor Antagonist Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Endothelin Receptor Antagonist Revenue Share by Manufacturers

Table 2016 USA Endothelin Receptor Antagonist Revenue Share by Manufacturers

Table USA Market Endothelin Receptor Antagonist Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Endothelin Receptor Antagonist Average Price of Key Manufacturers in 2015

Figure Endothelin Receptor Antagonist Market Share of Top 3 Manufacturers

Figure Endothelin Receptor Antagonist Market Share of Top 5 Manufacturers

Table USA Endothelin Receptor Antagonist Sales by Type (2011-2016)

Table USA Endothelin Receptor Antagonist Sales Share by Type (2011-2016)

Figure USA Endothelin Receptor Antagonist Sales Market Share by Type in 2015

Table USA Endothelin Receptor Antagonist Revenue and Market Share by Type (2011-2016)

Table USA Endothelin Receptor Antagonist Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Endothelin Receptor Antagonist by Type (2011-2016)

Table USA Endothelin Receptor Antagonist Price by Type (2011-2016)

Figure USA Endothelin Receptor Antagonist Sales Growth Rate by Type (2011-2016)

Table USA Endothelin Receptor Antagonist Sales by Application (2011-2016)

Table USA Endothelin Receptor Antagonist Sales Market Share by Application (2011-2016)

Figure USA Endothelin Receptor Antagonist Sales Market Share by Application in 2015

Table USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)

Figure USA Endothelin Receptor Antagonist Sales Growth Rate by Application (2011-2016)

Table Actelion Pharmaceuticals Ltd. Basic Information List

Table Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Actelion Pharmaceuticals Ltd. Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table United Therapeutics Corporation Basic Information List

Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table United Therapeutics Corporation Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Gilead sciences Basic Information List

Table Gilead sciences Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gilead sciences Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table SteadyMed Ltd. Basic Information List

Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table SteadyMed Ltd. Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table GlaxoSmithKline plc Basic Information List

Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline plc Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Reata Pharmaceuticals Inc. Basic Information List

Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Reata Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Arena Pharmaceuticals Inc. Basic Information List

Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals Inc. Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Merck & Co. Inc Basic Information List

Table Merck & Co. Inc Endothelin Receptor Antagonist Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Inc Endothelin Receptor Antagonist Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Endothelin Receptor Antagonist

Figure Manufacturing Process Analysis of Endothelin Receptor Antagonist

Figure Endothelin Receptor Antagonist Industrial Chain Analysis

Table Raw Materials Sources of Endothelin Receptor Antagonist Major Manufacturers in 2015

Table Major Buyers of Endothelin Receptor Antagonist

Table Distributors/Traders List

Figure USA Endothelin Receptor Antagonist Production and Growth Rate Forecast (2016-2021)

Figure USA Endothelin Receptor Antagonist Revenue and Growth Rate Forecast (2016-2021)

Table USA Endothelin Receptor Antagonist Production Forecast by Type (2016-2021)

Table USA Endothelin Receptor Antagonist Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370